NCT05774379

Brief Summary

It was planned to evaluate the effect of distraction intervention with virtual reality and fatigue education on the level of fatigue and anxiety in children with cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2023

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2023

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 17, 2023

Completed
Last Updated

March 17, 2023

Status Verified

March 1, 2023

Enrollment Period

10 months

First QC Date

March 7, 2023

Last Update Submit

March 7, 2023

Conditions

Keywords

virtual reality

Outcome Measures

Primary Outcomes (2)

  • fatigue

    Child Fatigue Scale-24 Hours: It consists of 10 items related to the perception of fatigue in children with cancer. The items in the scale contain statements that will show the child's experience of fatigue-related symptoms in the last 24 hours. The items were arranged according to likert scoring between 'never (1)' and 'a lot (5)'.

    pretest, 1., 2. and 3. days of chemotheraphy

  • anxiety

    The Children's Anxiety Meter (CAM-S). The Children's Anxiety Meter assesses children's anxiety and uses before medical procedures. This scale is drawn like a thermometer with a bulb at the bottom and also includes horizontal lines at intervals going up to the top (0-10). This scale ranges from 0 to 10. Higher values represent higher anxiety

    pretest, 1., 2. and 3. days of chemotheraphy

Study Arms (2)

virtual reality and fatigue education

EXPERIMENTAL

watching the application by wearing virtual glasses for 3 days and Providing training on fatigue to all children (1 session, average 45 minutes) (using role-play, exercise, games, coloring books and activity materials)

Device: virtual reality and fatigue education

fatigue education

EXPERIMENTAL

Providing training on fatigue to all children (1 session, average 45 minutes) (using role-play, exercise, games, coloring books and activity materials)

Behavioral: fatigue education

Interventions

virtual reality distraction for 3 days and fatigue education for children

virtual reality and fatigue education

fatigue education for children

fatigue education

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Be between 7-18 years old
  • Inpatient chemotherapy treatment for more than three days
  • weeks over the time of diagnosis (not in the induction phase)
  • Having a hemoglobin level above the criteria for transfusion of blood products (8 mg/dl for hematological malignancies, below 7 mg/dl for oncological malignancies).
  • The child voluntarily agrees to participate in the study and consent is obtained from the child and parent

You may not qualify if:

  • Being in terminal period
  • undergoing a surgical operation
  • Unwillingness to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gülçin Özalp Gerçeker

Izmir, 35100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

FatigueAnxiety Disorders

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Gülçin Özalp Gerçeker, pHD, RN

    Dokuz Eylul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
pHD, Assoc. Prof.

Study Record Dates

First Submitted

March 7, 2023

First Posted

March 17, 2023

Study Start

April 1, 2022

Primary Completion

February 1, 2023

Study Completion

February 10, 2023

Last Updated

March 17, 2023

Record last verified: 2023-03

Locations